Thoracic Oncology Group of Australasia shared a post on LinkedIn:
“Introducing the first instalment in our Clinical Trial Design Series!
This post explores how to get started with investigator-initiated trials, a must-read for clinicians and researchers looking to contribute to meaningful lung cancer research.
Read the full article.”
Megan Sanders, Chief Executive Officer at Thoracic Oncology Group of Australasia, shared this post, adding:
“Investigator-initiated trials are where many of the most clinically relevant questions get answered. But the process to get started isn’t always clear.
We’ve launched a new Clinical Trial Design Series to make that pathway clearer, starting with how to develop your concept to pitch to your peers.”
Other articles about Thoracic Oncology on OncoDaily.